Ovation Science (XCNQ:OVAT) FCF Margin % : -960.00% (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Ovation Science FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Ovation Science's Free Cash Flow for the three months ended in Dec. 2023 was C$-0.14 Mil. Ovation Science's Revenue for the three months ended in Dec. 2023 was C$0.02 Mil. Therefore, Ovation Science's FCF Margin % for the quarter that ended in Dec. 2023 was -960.00%.

As of today, Ovation Science's current FCF Yield % is -22.03%.

The historical rank and industry rank for Ovation Science's FCF Margin % or its related term are showing as below:

XCNQ:OVAT' s FCF Margin % Range Over the Past 10 Years
Min: -541.94 Med: -396.37 Max: -202.67
Current: -541.94

During the past 7 years, the highest FCF Margin % of Ovation Science was -202.67%. The lowest was -541.94%. And the median was -396.37%.

XCNQ:OVAT's FCF Margin % is ranked worse than
94.94% of 1027 companies
in the Drug Manufacturers industry
Industry Median: -0.03 vs XCNQ:OVAT: -541.94

Ovation Science FCF Margin % Historical Data

The historical data trend for Ovation Science's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ovation Science FCF Margin % Chart

Ovation Science Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-326.16

-202.67

-393.78

-486.23

-541.94

Ovation Science Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial															-466.67	-82.93	-4,650.00	-1,625.00	-960.00

Competitive Comparison of Ovation Science's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Ovation Science's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ovation Science's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ovation Science's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Ovation Science's FCF Margin % falls into.

Ovation Science FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Ovation Science's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-0.336	/	0.062
	=	-541.94 %

Ovation Science's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-0.144	/	0.015
	=	-960.00 %

Ovation Science FCF Margin % Related Terms

Thank you for viewing the detailed overview of Ovation Science's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Ovation Science (XCNQ:OVAT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ovation Science Inc (XCNQ:OVAT) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

OVATF:USA

Address

625 Howe Street, Suite 1140, Vancouver, BC, CAN, V6C 2T6

Website

https://www.ovationscience.com

Ovation Science Inc is a Canada-based company mainly engaged in the business of sub-licensing rights to use Invisicare, a patented drug delivery technology used in topical and transdermal skin products containing hemp seed oil and cannabis products. The company also holds the right to manufacture, distribute, sell, market, sub-license and promote products formulated with Invisicare and containing cannabis products including cannabinoids, hemp seed oil and any synthetic derivatives of cannabis. It also develops formulas for skin product lines including topical and transdermal creams and lotions containing hemp seed oil and cannabis.

Executives

David K. Ryan

Director

Ovation Science (XCNQ:OVAT) Headlines

No Headlines